Literature DB >> 33029737

A review of the role of genetic factors in Guillain-Barré syndrome.

Amin Safa1, Tahereh Azimi2, Arezou Sayad2, Mohammad Taheri3, Soudeh Ghafouri-Fard4.   

Abstract

Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy syndrome. Several genetic and environmental risk factors have been recognized for GBS. AS GBS is an immune-related disorder, abnormal functions of T cells, production of autoantibodies, and dysregulation of gene expression have been detected in GBS patients. Based on the critical role of human leukocyte antigen (HLA) in the regulation of immune responses, HLA alleles are among the mostly investigated loci in GBS. A number of polymorphisms within different genes, especially those linked with the regulation of immune responses, have been associated with GBS in different populations. Moreover, several studies have demonstrated abnormal expression of cytokine-coding genes in this disorder. Investigations in the animal model of GBS have also verified the aberrant regulation of Th1/Th2/Th17/Treg cytokines. In the current review, we describe the information about the role of these factors in GBS.

Entities:  

Keywords:  Genetic; Guillain–Barré syndrome; HLA; Polymorphism

Year:  2020        PMID: 33029737     DOI: 10.1007/s12031-020-01720-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  95 in total

1.  Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia.

Authors:  Stefan Blum; Stephen Reddel; Judy Spies; Pamela McCombe
Journal:  J Peripher Nerv Syst       Date:  2013-12       Impact factor: 3.494

2.  Genome-wide association study in Guillain-Barré syndrome.

Authors:  Stefan Blum; Ying Ji; David Pennisi; Zhixiu Li; Paul Leo; Pamela McCombe; Matthew A Brown
Journal:  J Neuroimmunol       Date:  2018-08-02       Impact factor: 3.478

3.  Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.

Authors:  Christina M Caporale; Franco Papola; Maria A Fioroni; Anna Aureli; Armando Giovannini; Francesca Notturno; Domenico Adorno; Vincenzo Caporale; Antonino Uncini
Journal:  J Neuroimmunol       Date:  2006-07-03       Impact factor: 3.478

4.  IL-8 as a potential biomarker in Guillain-Barre Syndrome.

Authors:  Gautier Breville; Agustina M Lascano; Pascale Roux-Lombard; Patrice H Lalive
Journal:  Eur Cytokine Netw       Date:  2019-12-01       Impact factor: 2.737

5.  Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré Syndrome.

Authors:  Stefan Blum; Peter Csurhes; Stephen Reddel; Judy Spies; Pamela McCombe
Journal:  J Neuroimmunol       Date:  2013-12-12       Impact factor: 3.478

6.  Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal.

Authors:  M P Chalon; C J Sindic; E C Laterre
Journal:  Acta Neurol Scand       Date:  1993-02       Impact factor: 3.209

7.  Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.

Authors:  Stefan Blum; Pamela A McCombe
Journal:  J Peripher Nerv Syst       Date:  2014-06       Impact factor: 3.494

8.  Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barré syndrome.

Authors:  S Bansil; F A Mithen; S D Cook; A Sheffet; C Rohowsky-Kochan
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

9.  Identification of gene networks and pathways associated with Guillain-Barré syndrome.

Authors:  Kuo-Hsuan Chang; Tzi-Jung Chuang; Rong-Kuo Lyu; Long-Sun Ro; Yih-Ru Wu; Hong-Shiu Chang; Chin-Chang Huang; Hung-Chou Kuo; Wen-Chuin Hsu; Chun-Che Chu; Chiung-Mei Chen
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

10.  A report of a probable case of familial Guillain Barre syndrome.

Authors:  Mohammad Barzegar; Amir Hossein Jafari Rouhi; Mehdi Farhoudi; Sara Sardashti
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

View more
  3 in total

1.  Computational Identification of Guillain-Barré Syndrome-Related Genes by an mRNA Gene Expression Profile and a Protein-Protein Interaction Network.

Authors:  Chunyang Wang; Shiwei Liao; Yiyi Wang; Xiaowei Hu; Jing Xu
Journal:  Front Mol Neurosci       Date:  2022-03-17       Impact factor: 5.639

2.  Dysregulation of lncRNAs in autoimmune neuropathies.

Authors:  Mahdi Gholipour; Mohammad Taheri; Jafar Mehvari Habibabadi; Naghme Nazer; Arezou Sayad; Soudeh Ghafouri-Fard
Journal:  Sci Rep       Date:  2021-08-09       Impact factor: 4.379

3.  Assessment of Expression of SOCS Genes in Acquired Immune-Mediated Polyneuropathies.

Authors:  Mohammad Taheri; Somayeh Sangseifid; Pariya Shahani; Mohammad Mahdi Eftekharian; Shahram Arsang-Jang; Soudeh Ghafouri-Fard
Journal:  Front Immunol       Date:  2021-07-19       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.